Brainstorm Cell Therapeutics Inc.
BCLI
$1.21
-$0.0053-0.43%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -85.62% | -88.15% | 363.77% | -65.02% | -56.42% |
Total Receivables | 23.53% | -39.39% | -64.52% | -40.91% | -43.96% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -75.36% | 183.64% | -15.59% | -31.00% | 1,612.50% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -79.73% | -76.35% | 214.59% | -57.02% | -38.86% |
|
|||||
Total Current Assets | -79.73% | -76.35% | 214.59% | -57.02% | -38.86% |
Net Property, Plant & Equipment | -40.88% | -64.63% | -63.03% | -61.65% | -60.49% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -100.00% | -- | -- | -- | -66.67% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -0.48% | 866.67% | 804.55% | 778.26% | 800.00% |
Total Assets | -56.46% | -64.36% | -1.11% | -57.47% | -50.21% |
|
|||||
Total Accounts Payable | 22.73% | 17.24% | 2.89% | -39.89% | -20.40% |
Total Accrued Expenses | -50.08% | 1,273.02% | 697.78% | 271.93% | 1,376.19% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -8.96% | -56.36% | -58.20% | -57.67% | -57.74% |
Total Finance Division Other Current Liabilities | 42.57% | 1.75% | 0.95% | -13.49% | -5.82% |
Total Other Current Liabilities | 42.57% | 1.75% | 0.95% | -13.49% | -5.82% |
Total Current Liabilities | 15.10% | 12.04% | 0.00% | -34.46% | -11.36% |
|
|||||
Total Current Liabilities | 15.10% | 12.04% | 0.00% | -34.46% | -11.36% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -74.55% | -82.90% | -79.57% | -76.72% | -74.79% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -24.75% | 103.63% | -- | -- | -- |
Total Liabilities | 5.85% | -2.20% | -4.35% | -30.00% | -20.93% |
|
|||||
Common Stock & APIC | 4.15% | 5.20% | 6.41% | 7.48% | 7.87% |
Retained Earnings | -5.41% | -6.79% | -6.12% | -7.66% | -8.69% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | -59.82% | -134.59% | 9.14% | -14.67% | -61.13% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -59.82% | -134.59% | 9.14% | -14.67% | -61.13% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -59.82% | -134.59% | 9.14% | -14.67% | -61.13% |
|